Connection

Mahmudul Hasan to Humans

This is a "connection" page, showing publications Mahmudul Hasan has written about Humans.
Connection Strength

0.064
  1. Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach. Biomed Pharmacother. 2021 Aug; 140:111742.
    View in: PubMed
    Score: 0.008
  2. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach. Comput Biol Med. 2021 07; 134:104451.
    View in: PubMed
    Score: 0.008
  3. Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine. Infect Genet Evol. 2020 11; 85:104517.
    View in: PubMed
    Score: 0.007
  4. Contriving a chimeric polyvalent vaccine to prevent infections caused by herpes simplex virus (type-1 and type-2): an exploratory immunoinformatic approach. J Biomol Struct Dyn. 2020 Jul; 38(10):2898-2915.
    View in: PubMed
    Score: 0.007
  5. Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus. Microb Pathog. 2019 May; 130:19-37.
    View in: PubMed
    Score: 0.006
  6. Antibody-Drug Conjugates: A Review on the Epitome of Targeted Anti- Cancer Therapy. Curr Clin Pharmacol. 2018; 13(4):236-251.
    View in: PubMed
    Score: 0.006
  7. The Immunopathobiology of SARS-CoV-2 Infection. FEMS Microbiol Rev. 2021 11 23; 45(6).
    View in: PubMed
    Score: 0.002
  8. Digital solutions for continued operation of WRRFs during pandemics and other interruptions. Water Environ Res. 2021 Nov; 93(11):2527-2536.
    View in: PubMed
    Score: 0.002
  9. Diagnostics for SARS-CoV-2 infections. Nat Mater. 2021 05; 20(5):593-605.
    View in: PubMed
    Score: 0.002
  10. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. J Neuroimmune Pharmacol. 2021 06; 16(2):270-288.
    View in: PubMed
    Score: 0.002
  11. Nanocarrier vaccines for SARS-CoV-2. Adv Drug Deliv Rev. 2021 04; 171:215-239.
    View in: PubMed
    Score: 0.002
  12. Pharmacotherapeutics of SARS-CoV-2 Infections. J Neuroimmune Pharmacol. 2021 03; 16(1):12-37.
    View in: PubMed
    Score: 0.002
  13. Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach. Int J Biol Macromol. 2020 Nov 15; 163:1787-1797.
    View in: PubMed
    Score: 0.002
  14. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol. 2020 09; 15(3):359-386.
    View in: PubMed
    Score: 0.002
  15. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective. Infect Genet Evol. 2020 Oct; 84:104440.
    View in: PubMed
    Score: 0.002
  16. Immunoinformatics approaches for designing a novel multi epitope peptide vaccine against human norovirus (Norwalk virus). Infect Genet Evol. 2019 10; 74:103936.
    View in: PubMed
    Score: 0.002
  17. Prevalence of Avian Influenza A(H5) and A(H9) Viruses in Live Bird Markets, Bangladesh. Emerg Infect Dis. 2018 12; 24(12):2309-2316.
    View in: PubMed
    Score: 0.002
  18. Handwritten Bangla Character Recognition Using the State-of-the-Art Deep Convolutional Neural Networks. Comput Intell Neurosci. 2018; 2018:6747098.
    View in: PubMed
    Score: 0.002
  19. Investigation of calcium-dependent activity and conformational dynamics of zebra fish 12-lipoxygenase. Biochim Biophys Acta Gen Subj. 2017 Aug; 1861(8):2099-2111.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.